摘要
目的:评价半导体激光经巩膜睫状体光凝术(diode lasertr anscleral cyclophotocoagulation,DL Tscpc)治疗难治性青光眼的远期疗效。方法:对431眼难治性青光眼采用低能量1.5～2.5W,多点数26～34的DLTscpc,术后随访观察并记录眼压,视力,眼部自觉症状以及并发症,随访时间36mo以上。结果:术前平均眼压(56.2±12.7)mmHg,最后随访平均眼压为(17.3±8.8)mmHg,经配对资料t检验,术前眼压与术后眼压相比,差别具有统计学意义(P<0.05)。手术有效率97.5%。术后399眼视力无变化,30眼视力提高,2眼视力下降。术前有眼痛的患者眼痛均消失或缓解,并发症少,程度轻,主要有色素膜炎,前房出血等,2眼眼球萎缩。结论:经长期随访观察,DLTscpc是治疗难治性青光眼的一种简单,安全有效的方法。
AIM： To evaluate the long-term efficiency of diode laser transscleral cyclophotocoagulation （DL Tscpc） for refractory glaucoma.
METHODS： Retrospective analysis was made in 431 eyes with refractory glaucoma treated by DL Tscpc with lower energy power （1.5-2.5W） and more laser spots （26-34）. Intraocular pressure （IOP）, visualacuity, ocular symptoms and complications were observed after DL Tscpc. Patients were followed up over 36 months
RESULTS： Mean pre-operative IOP was （56.2±12.7）mmHg which was significantly different from the final follow-up mean IOP （17.3±8.8）m mHg. （P〈 0.05）. The success rate was 94.4% （68/72）. Postoperative visual acuity kept no change in 399 eyes, elevated in 30 eyes and decreased in two eyes. The pain sense disappeared or remarkably relieved. The main complications included mild uveitis and hyphemae. Atrophy of eyeball occurred in two eyes.
CONCLUSION： It is conduded that DL TScpc is a simple, safe and effective therapy for eyes with refractory glaucoma through long-term observation.
出处
《国际眼科杂志》
CAS
2007年第2期524-525,共2页
International Eye Science
